Please use this identifier to cite or link to this item:
Title: Zika virus infection in pregnancy: a systematic review of disease course and complications
Author: Chibueze, Ezinne C.
Tirado, Veronik
Lopes, Katharina da Silva
Balogun, Olukunmi O.
Takemoto, Yo
Swa, Toshiyuki
Dagvadorj, Amarjargal
Nagata, Chie
Morisaki, Naho
Menéndez, Clara
Ota, Erika
Mori, Rintaro
Oladapo, Olufemi T.
Keywords: Virus
Issue Date: 2017
Publisher: BioMed Central
Abstract: OBJECTIVES: To characterize maternal Zika virus (ZIKV) infection and complement the evidence base for the WHO interim guidance on pregnancy management in the context of ZIKV infection. METHODS: We searched the relevant database from inception until March 2016. Two review authors independently screened and assessed full texts of eligible reports and extracted data from relevant studies. The quality of studies was assessed using the Newcastle-Ottawa Scale (NOS) and the National Institute of Health (NIH) tool for observational studies and case series/reports, respectively. RESULTS: Among 142 eligible full-text articles, 18 met the inclusion criteria (13 case series/reports and five cohort studies). Common symptoms among pregnant women with suspected/confirmed ZIKV infection were fever, rash, and arthralgia. One case of Guillain-Barre syndrome was reported among ZIKV-infected mothers, no other case of severe maternal morbidity or mortality reported. Complications reported in association with maternal ZIKV infection included a broad range of fetal and newborn neurological and ocular abnormalities; fetal growth restriction, stillbirth, and perinatal death. Microcephaly was the primary neurological complication reported in eight studies, with an incidence of about 1% among newborns of ZIKV infected women in one study. CONCLUSION: Given the extensive and variable fetal and newborn presentations/complications associated with prenatal ZIKV infection, and the dearth of information provided, knowledge gaps are evident. Further research and comprehensive reporting may provide a better understanding of ZIKV infection in pregnancy and attendant maternal/fetal complications. This knowledge could inform the creation of effective and evidence-based strategies, guidelines and recommendations aimed at the management of maternal ZIKV infection. Adherence to current best practice guidelines for prenatal care among health providers is encouraged, in the context of maternal ZIKV infection.
Note: Reproducció del document publicat a:
It is part of: Reproductive Health, 2017, vol. 14, num. 28
Related resource:
ISSN: 1742-4755
Appears in Collections:Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
chibueze2017_2454.pdf584.13 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons